Cramer Rosenthal McGlynn’s Adtran ADTN Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio ADTN Stock Details ADTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-287,178	Closed	-$3.61M	–	97
2026 Q1	$3.61M	Buy	+287,178	New	+$2.91M	0.27%	81

Other funds holding ADTN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cramer Rosenthal McGlynn's ADTN Position: Q2 2026 in Review

Cramer Rosenthal McGlynn sold out of Adtran (ADTN) in Q2 2026, closing a stake of 287,178 shares — an estimated $3.61M sold.

Cramer Rosenthal McGlynn first reported a position in ADTN in Q1 2026 and held it in 1 quarter. The position peaked at $3.61M in Q1 2026. 249 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

Cramer Rosenthal McGlynn reported no remaining Adtran position as of Q2 2026 after selling out during the quarter.
Cramer Rosenthal McGlynn sold 287,178 Adtran shares in Q2 2026, an estimated $3.61M.
Cramer Rosenthal McGlynn first reported a position in Adtran in Q1 2026 and held it in 1 quarter.
Cramer Rosenthal McGlynn's Adtran position peaked at $3.61M in Q1 2026.
249 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2026, filed 13 Aug 2026.